The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Accelerator ™ Drug Development: Collaborative timeline management drives speed and simplicity in global vaccine trial
Case study
When a global biopharma company set aggressive milestones for a high-stakes Phase III vaccine trial, complexity across geographies, supply chains, and regulatory requirements threatened to delay first patient in (FPI). Through the Accelerator™ Drug Development framework, Thermo Fisher Scientific helped align timelines, resolve quality agreement discrepancies, and streamline execution—enabling five weeks of time savings and on-time startup across more than 170 sites worldwide. Discover how collaborative oversight turned a high-risk timeline into a repeatable success.
Additional resources
Blog post
The Science of Cell Line Development for Biologics
Cell line development is critical to biologics manufacturing, influencing efficiency, scalability, and product stability. Advances in CHO-K1 cell line engineering, are driving higher yields, improved gene stability, and faster IND submission pathways.